Table 3.
Fold Change in the Expression of Anti-Apoptosis Marker Genes in PBM Cells Infected with Wild-Type (WT) and Mutant Viruses with Respect to Uninfected Cells
|
WT |
K65R |
M184V |
PSD 5.1a |
PSD 5.2b |
|||||
---|---|---|---|---|---|---|---|---|---|---|
Anti-apoptosis marker genes | Day 1 | Day 7 | Day 1 | Day 7 | Day 1 | Day 7 | Day 1 | Day 7 | Day 1 | Day 7 |
AKT1 | 1.05 | −1.81 | −4.82 | −1.18 | 1.78 | −1.42 | 1.89 | −1.52 | 2.02 | 1.02 |
BAG1 | 1.47 | −1.32 | 3.32 | 1.04 | 2.91 | 1.68 | 2.57 | 1.49 | 2.18 | −1.27 |
BAG3 | −5.00 | −2.13 | −6.44 | −1.32 | −4.10 | −1.57 | −3.08 | −2.47 | −3.39 | −1.43 |
BCL2 | −2.05 | 1.01 | −2.51 | 1.65 | −2.06 | 1.02 | −2.40 | −1.17 | −2.50 | −1.11 |
BCL2A1 | −1.36 | −1.28 | −1.16 | −1.19 | −1.01 | −1.40 | 1.11 | −1.14 | 1.89 | 1.63 |
BCL2L1 | 1.88 | 2.27 | −2.74 | 2.36 | 1.97 | 2.36 | 2.36 | 1.69 | 1.32 | 1.65 |
BCL2L2 | −2.15 | −2.35 | −2.48 | −1.36 | −2.83 | −6.98 | −1.72 | −2.30 | −1.73 | −4.49 |
BFAR | −3.58 | −4.27 | −13.94 | −4.74 | −3.04 | −4.65 | −3.23 | −4.18 | 1.70 | 1.13 |
NAIP | −2.55 | −3.16 | −6.66 | −3.44 | −3.33 | −2.32 | −2.91 | −4.60 | −1.53 | −3.03 |
BIRC2 | −1.35 | −1.50 | −11.84 | −1.20 | −1.28 | −1.66 | −1.28 | 1.61 | 1.26 | 1.03 |
BIRC3 | −1.54 | 1.38 | −3.95 | 1.65 | −1.29 | 1.45 | −1.27 | 1.26 | −1.13 | 1.26 |
BIRC6 | 1.49 | 2.02 | 3.85 | 1.95 | 1.40 | 2.24 | 1.55 | 1.70 | −1.93 | 1.03 |
BIRC8 | −1.28 | 1.62 | 1.42 | 1.31 | −2.06 | 1.39 | −1.04 | 1.14 | 1.15 | 1.20 |
BNIP1 | −2.95 | −2.20 | −15.46 | −1.38 | −1.71 | −1.36 | −2.03 | −2.12 | −1.06 | 1.52 |
BNIP2 | 2.11 | 1.85 | 1.27 | 2.25 | 2.17 | 1.73 | 1.96 | 1.37 | 1.10 | −1.10 |
BNIP3 | −19.56 | −2.59 | −39.89 | −2.14 | −14.59 | −2.58 | −16.68 | −3.31 | −11.82 | −1.49 |
BRAF | −1.68 | −1.27 | 1.25 | 3.29 | 1.57 | 1.08 | 1.03 | −1.41 | 1.44 | 1.09 |
CASP2 | 1.43 | 1.60 | −1.98 | 1.82 | 1.32 | 1.65 | 1.64 | −1.12 | 1.39 | −1.04 |
CFLAR | −3.62 | −1.65 | -17.86 | −1.58 | −2.62 | −1.81 | −2.70 | −1.73 | −1.62 | 1.06 |
FAS | −1.40 | 1.61 | −3.98 | 1.81 | −1.53 | 1.59 | −1.19 | 1.21 | −1.29 | 1.66 |
IGF1R | −1.42 | 1.78 | −1.51 | 2.43 | −1.22 | 1.50 | −1.33 | 1.17 | −1.67 | −1.15 |
MCL1 | 1.38 | 1.78 | 3.90 | 2.04 | 1.51 | 1.74 | 1.70 | 1.38 | 1.05 | 1.09 |
TNF | 2.04 | 1.32 | 4.89 | 1.25 | 2.08 | −1.00 | 2.72 | −1.47 | 1.92 | 1.48 |
CD27 | −1.42 | −1.03 | 1.84 | 1.29 | −1.26 | 1.03 | 1.19 | −1.03 | −1.21 | −1.18 |
No. of genes up-regulated/no. of genes downregulated | 8/16 | 11/13 | 8/16 | 14/10 | 9/15 | 13/11 | 11/13 | 9/15 | 12/12 | 14/10 |
PSD 5.1 (pNL4-3) contains RT fragment from a clinical isolate containing K65R, D67N, S68G, K70R, K103N, T215Y, and K219E mutations.
PSD5.2 is a variant of PSD5.1 and lacks the K65R mutation. This variant replicates efficiently in PBM cells (see Fig. 1).
Numbers in bold indicate > 1.5-fold increased expression of specific AAMG on day 7 post-infection of PBM cells by mutant viruses in comparison to WT virus.
Minus sign before numbers indicates downregulation.
PBM, peripheral blood mononuclear; AAMG, anti-apoptosis marker gene.